YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
[Close-Up Shot of Scientists Hands typing Data in Laptop in Laboratory] Tom Werner Healthcare stocks underperformed the broader market in September, with the Health Care Select Sector SPDR Fund (XLV [https://seekingalpha.com/symbol/XLV]) f…
2 Safe-and-Steady Stocks to Consider Right Now and 1 Facing Challenges A stock with low volatility can be reassuring, but it doesn't always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward…
ACTON, Mass., October 01, 2026--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced it will report financi…
Insulet has seen its share price fall hard over the past year, which puts the focus squarely on whether the current market value still lines up with the cash the business is expected to generate. With the stock under pressure, the key issu…
2 Healthcare Stocks with Impressive Fundamentals and 1 Facing Challenges Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only realized stron…
Insulet (PODD) recently reworked its financing by replacing $475 million of term loans with new debt at lower interest margins and expanding its revolving credit facility, a move that directly reshapes the balance sheet. Insulet's refinanc…
Firing on All Cylinders: iRhythm (NASDAQ:IRTC) Q2 Earnings Lead the Way The end of the earnings season is always a good time to take a step back and see who shined (and who didn't). Let's take a look at how patient monitoring stocks fared…
ACTON, Mass., September 18, 2026--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at Bernstein Ins…
Baron Capital, an investment management company, released its second-quarter 2026 investor letter for its "Baron SMID Cap ETF". You can download the letter here. Baron SMID Cap ETF® (BCSM) gained 15.62% (NAV) in the second quarter, underpe…
Patient Monitoring Stocks Q2 Teardown: ResMed (NYSE:RMD) Vs The Rest Wrapping up Q2 earnings, we look at the numbers and key takeaways for the patient monitoring stocks, including ResMed (NYSE:RMD) and its peers. Patient monitoring compani…
2 S&P 500 Stocks with Impressive Fundamentals and 1 We Turn Down The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn't mean every stock is worth owning. Some companies face significant challenges, whether…
Wall Street rallied on Friday after the latest consumer inflation report came in broadly in line with expectations, helping ease concerns over price pressures and supporting a rebound across risk assets. On Friday, the Dow Jones Industrial…
Insulet PODD is well poised for growth in the upcoming quarters, owing to its strong momentum for the Omnipod 5 automated insulin delivery ("AID") system for both Type 1 and Type 2 populations. The company is strongly executing against its…
Artisan Partners, an investment management company, released its second-quarter 2026 investor letter for the "Artisan Mid Cap Fund". The letter can be downloaded here. Global equities rebounded sharply in Q2 2026, recovering from March low…
[Health Care Medical Concept] ogichobanov/iStock via Getty Images The healthcare sector (XLV [https://seekingalpha.com/symbol/XLV]) gained 4.91% in August, outperforming the broader S&P 500 (SPY [https://seekingalpha.com/symbol/SPY]), whic…
A month has gone by since the last earnings report for Insulet (PODD). Shares have added about 8.1% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is Insul…
Unpacking Q2 Earnings: Insulet (NASDAQ:PODD) In The Context Of Other Patient Monitoring Stocks As the Q2 earnings season wraps, let's dig into this quarter's best and worst performers in the patient monitoring industry, including Insulet (…
Q2 Earnings Highs And Lows: DexCom (NASDAQ:DXCM) Vs The Rest Of The Patient Monitoring Stocks Wrapping up Q2 earnings, we look at the numbers and key takeaways for the patient monitoring stocks, including DexCom (NASDAQ:DXCM) and its peers…
Insulet stock has fallen sharply over the past year, yet both an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach and market multiples currently point to the shares trading below what those models suggest, while the…
Insulet (PODD) is back in focus after ongoing reminders about a securities class action lawsuit tied to alleged issues in its manufacturing controls and recent voluntary Medical Device Corrections disclosed in March and May 2026. At a shar…
[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images With the second-quarter earnings season now largely behind us, investors are turning their attention to how healthcar…
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. The U.S. Food and Drug Administration (FDA) on Tuesday approved Abbott Laboratories' Libre Duo 10 Day Continuous Dual Glucose Ketone Monit…
NEW YORK, Aug. 26, 2026 /PRNewswire/ -- Bloomberg Indices announced the following changes to the Bloomberg 500 (B500) Index, effective prior to the open of trading on Thursday, September 10, 2026, to coincide with the September reconstitut…
The U.S. Food and Drug Administration (FDA) on Tuesday approved Abbott Laboratories' (NYSE:ABT) Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for diabetes patients aged two and older. The regulatory nod makes the device…
Company Logo Opportunities include AI-enabled adherence platforms, connected inhalers, injectors and smart packaging, telehealth and home-care integration, chronic disease support, and pharmacy-led services in underserved and Asia-Pacific…
ACTON, Mass., August 26, 2026--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at the Wells Fargo…
3d illustration inflation and deflation graph by Deepadesigns via Shutterstock Insulet Corporation (PODD), headquartered in Acton, Massachusetts, operates as an innovative medical device company. Valued at $10.1 billion by market cap, the…
Estée Lauder earns a rank among high-growth stocks beyond AI. - Ian Langsdon/Agence France-Presse/Getty Images In 2021 strategists at Bank of America's BofA Securities advised clients to "stick with large-cap value until everyone's talking…
Insulet Corporation PODD delivered a second-quarter earnings and revenue beat, supported by double-digit Omnipod growth and wider adjusted margins. The stronger quarter, however, came alongside a lower 2026 revenue-growth outlook. That res…
Ashley McEvoy, the President and CEO of Insulet Corporation (NASDAQ:PODD), purchased 1,100 shares of common stock on Aug. 21, 2026. SEC Form 4 filing. Transaction summary Metric Value Transaction value $162,217 Shares purchased 1,100 Post-…
3 Mid-Cap Stocks with Competitive Advantages Large trillion-dollar companies are tightening their grip on the market, often by acquiring smaller rivals. This trend will likely pick up with new regulatory leadership, but a few mid-sized bus…
Healthcare Equipment and Supplies Stocks Q2 In Review: QuidelOrtho (NASDAQ:QDEL) Vs Peers The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let'…
5 Must-Read Analyst Questions From Insulet's Q2 Earnings Call Insulet's second quarter was marked by strong revenue expansion but a sharp negative market reaction, as investors focused on emerging challenges in the company's type 2 diabete…
Alpha Wealth Funds, LLC, an investment management company, released its Q2 2026 letter for the "Insiders Fund". A copy of the letter is available to download here. The Fund lost 1.45% in June, while it was up 8.43% for the 2nd quarter and…
Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 8:00 a.m. ET CALL PARTICIPANTS Vice President, Investor Relations - Clare Trachtman President and Chief Executive Officer - Ashley McEvoy Chief Financial Officer - Flavia Pease…
Insulet Corporation PODD reported second-quarter 2026 adjusted earnings per share (EPS) of $1.66, up 41.5% year over year. The bottom line beat the Zacks Consensus Estimate by 15.28%. GAAP EPS came in at $1.37 compared with the year-ago qu…